Portfolio company NXThera was acquired by Boston Scientific for approximately $400M.
MAR 2018
NxThera is a mid-sized medical device company based in Maple Grove, Minnesota, founded in 2008
NxThera is a mid-sized medical device company based in Maple Grove, Minnesota, founded in 2008. It developed a therapy platform that uses convective water vapor energy to treat endourological conditions, with an initial indication for benign prostatic hyperplasia cleared by the FDA in August 2015. The Rezûm System delivers sterile water vapor to targeted tissue during office-based or outpatient procedures, aiming to relieve lower urinary tract symptoms, improve urine flow, and enhance quality of